安旭生物 (688075.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(安旭生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年第一季度2021年第四季度2021年第三季度2021年第二季度2021年第一季度2020年第四季度2020年第三季度
上市前/上市后 上市后上市后上市前上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 5,474,543,757.08907,290,078.32187,967,600.05302,832,116.37191,189,307.66729,692,276.98162,442,100.91
 营业收入(元) 5,474,543,757.08907,290,078.32187,967,600.05302,832,116.37191,189,307.66729,692,276.98162,442,100.91
二、营业总成本(元) 2,329,561,768.93352,956,328.2298,596,126.29168,334,699.1392,732,699.09264,714,270.4765,904,734.88
 营业成本(元) 1,207,182,125.76267,708,732.5180,767,226.38123,387,606.3977,317,308.92186,075,378.7435,364,547.85
 研发费用(元) 555,198,928.0340,041,818.2111,252,752.8612,352,497.696,732,736.6035,123,009.766,702,304.62
 营业税金及附加(元) 27,056,412.104,835,997.181,723,645.582,173,635.463,183,901.434,352,480.211,399,244.96
 销售费用(元) 508,541,363.6411,199,882.103,279,594.0810,657,313.035,709,955.9710,636,729.765,780,233.42
 管理费用(元) 27,278,847.3810,526,882.365,185,102.326,933,480.534,564,756.807,328,978.843,484,215.98
 财务费用(元) 4,304,092.0218,643,015.86-3,612,194.9312,830,166.03-4,775,960.6321,197,693.1613,174,188.05
  其中:利息费用(元) -43,087.2541,065.60--32,695.00-
  其中:利息收入(元) -1,614,246.6228,357.07--133,431.3333,315.30
 资产减值损失(元) -25,286,000.00-9,897,432.74-338,459.1892,591.96-1,026,257.29-362,166.85-551,249.95
 信用减值损失(元) --18,109,134.74-1,228,705.59---3,387,655.40-2,164,932.82
三、其他经营收益
 加:投资收益(元) 137,100.008,870,547.381,222,626.691,501,560.85245,430.65889,209.91311,188.16
 资产处置收益(元) -28,216.48-----
 其他收益(元) -1,016,000.00602,000.00--860,930.641,662,749.30
四、营业利润(元) 3,119,833,088.15536,343,451.3189,628,935.68141,425,032.6597,675,781.93462,978,324.8195,723,931.23
 加:营业外收入(元) 70,535.10774.055,740.71-133,473.88138,491.134,903.01566.68
 减:营业外支出(元) 3,581,079.42212,376.53228,811.072,762.0021,004.99109,660.10402.67
五、利润总额(元) 3,116,322,543.83536,131,848.8389,405,865.32141,288,796.7797,793,268.07462,873,567.7295,724,095.24
 减:所得税费用(元) 434,622,528.8681,510,160.997,620,772.3321,737,303.6115,225,271.9766,688,288.7714,669,678.18
六、净利润(元) 2,681,700,014.97454,621,687.8481,785,092.99119,551,493.1682,567,996.10396,185,278.9581,054,417.06
(一)按经营持续性分类
  持续经营净利润(元) 2,681,700,014.97454,621,687.8481,785,092.99119,551,493.1682,567,996.10396,185,278.9581,054,417.06
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 2,681,700,014.97454,621,687.8481,785,092.99119,551,493.1682,567,996.10396,185,278.9581,054,417.06
 扣除非经常性损益后的净利润(元) 2,684,463,498.22446,394,213.1880,359,800.00--394,793,400.0079,433,100.00
七、每股收益
 一、基本每股收益(元) 43.779.451.782.601.798.611.77
 二、稀释每股收益(元) 43.779.451.782.601.798.611.77
八、其他综合收益(元) 2,589,324.05-12,641.29-247,907.82767,387.15-72,899.92951,593.09-353,500.60
 归属于母公司股东的其他综合收益(元) 2,589,324.05-12,641.29-247,907.82767,387.15-72,899.92951,593.09-353,500.60
九、综合收益总额(元) 2,684,289,339.02454,609,046.5581,537,185.17120,318,880.3182,495,096.18397,136,872.0480,700,916.46
 归属于母公司所有者的综合收益总额(元) 2,684,289,339.02454,609,046.5581,537,185.17120,318,880.3182,495,096.18397,136,872.0480,700,916.46
公告日期 2022-04-282022-04-282021-11-172021-10-212022-04-282021-09-272021-11-17
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见

前瞻产业研究院